Low-grade endometrioid carcinoma is characterized by ARID1A mutations in one-third of the tumours20, as well as CTNNB1 mutations21, PTEN mutations22 and PIK3CA mutations23. Here, CTNNB1 is linked to endometrioid adenocarcinoma.